Related Experiment Video
Updated: Jun 30, 2026
12:17
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
[IgM antiphospholipical antibodies in preeclampsia-eclampsia]
Jesús Carlos Briones-Garduño1, Manuel Díaz de León-Ponce, Ernesto Barrios-Prieto
1Unidad de Investigación en Preeclampsia-Eclampsia, Instituto Materno-Infantil del Estado de México, Laguna de Colores No. 101, Esq. Lago Caimanero, C.P. 50100, Toluca, Edo. de Méx., México.
Cirugia Y Cirujanos
|February 27, 2004
Summary
Antiphospholipid antibodies, specifically anticardiolipin antibodies (IgM isotype), are linked to endothelial damage and complications in preeclampsia-eclampsia. Elevated IgM levels suggest an immunologic mechanism during acute disease states.
Area of Science:
- Obstetrics and Gynecology
- Immunology
- Perinatology
Context:
- Preeclampsia-eclampsia is a serious pregnancy complication.
- Antiphospholipid antibodies are implicated in thrombocytopenia and fetal loss.
- Elevated antiphospholipid antibodies have been observed in preeclampsia patients.
Purpose:
- To investigate the presence of anticardiolipin antibodies (IgG-IgM) as indicators of endothelial damage in preeclampsia.
- To assess the role of anticardiolipin antibodies in the pathophysiology of preeclampsia.
Summary:
- A case-control study compared 18 preeclampsia-eclampsia patients with 18 normal pregnancies.
- Anticardiolipin antibodies (IgG-IgM), coagulation tests, and clinical variables were analyzed.
- Significant differences in IgM levels, newborn outcomes, and maternal complications like HELLP syndrome were noted.
Impact:
- Results suggest an immunologic mechanism driving anticardiolipin antibody (IgM) synthesis during acute preeclampsia.
- This mechanism contributes to vascular changes and a prothrombotic state.
- Findings highlight potential links between anticardiolipin antibodies and maternal/neonatal complications in preeclampsia.
